Mammary carcinomas that develop in C3 ( 1 ) / SV40 T -antigen ( TAg ) transgenic mice have lost the p53 -mediated induction of p21, leading to increased cellular proliferation and significant elevations of cyclins and Cdks. To test whether p21 could serve as a target for anticancer therapy for this mammary cancer model, a retroviral delivery system for the inducible expression of p21 was developed. We demonstrate that overexpression of p21 in C3 ( 1 ) / TAg mammary tumor cells using the retroviral inducible p21 expression system results in increased apoptosis, reduced cell proliferation in vitro and reduced tumor growth in vivo associated with reduced expression of cyclins D1 and E, and Cdks 2, 4, and 6. Reciprocal changes in the expression of p21 and p27
N ormal cell growth is dependent on the tightly regulated activation and inactivation of cyclin /cyclin-dependent kinase (Cdk ) complexes, which enable the cell to pass through a series of checkpoints in the cell cycle. 1 Disturbances in the regulation of cyclin /Cdk activity may accelerate cell -cycle progression, resulting in unchecked cell proliferation and neoplasia. 2 These check points are controlled by the synthesis and proteolysis of cyclins and the phosphorylation of Cdks. In addition, cyclin/ CdK activity is regulated by CdK inhibitors, which bind to and inactivate Cdk complexes. 2, 3 The Cdk inhibitor p21, a critical regulator of cell -cycle progression, may play an important role in the progression of human breast cancer (Fig 1) . 4 p21 is directly up -regulated by p53 at the transcriptional level. 5 p53 mutations have been reported in approximately 40% of human breast tumors and correlate with a poor prognosis. 6 ± 8 Because p53 function is commonly lost in human breast cancer, normal p21 functions are also often abrogated during mammary tumor progression. The lack of p21 expression may be a marker for an increased recurrence risk of human breast cancer. 9 Under normal circumstances, p21 is induced following DNA damage, 5, 10 and blocks cell -cycle progression from the G1 to S phase. 11 This pause in cell -cycle progression allows for DNA repair to occur before the replication of DNA in the S phase. p21 has also been shown to inhibit both PCNA -dependent DNA replication 12 and phosphorylation of Rb. 13 Phosphorylation of Rb is required for progression of the cell cycle from G1 to S, and for activation of E2F -mediated transcription of several growth -related genes.
Previous studies have demonstrated that the introduction of exogenous p21 into several types of tumor cells can often suppress their growth. 5,14 ± 18 However, few studies have addressed whether overexpression of p21 can inhibit tumor formation in vivo. 17, 18 Recent studies suggest that a reduction of p21 gene dosage can promote tumor formation and /or progression in mammary glands of Wnt -1 transgenic mice with p21 mutant alleles. 19 We have previously reported that p21 expression is lost during mammary tumor development in C3 ( 1) / TAg transgenic mice, 20 a model which shares several important histologic and molecular features with human breast cancer. 21 ± 23 The TAg -induced functional inactivation of two critical tumor suppressor genes, p53 and Rb, leads to significant dysfunction of cell-cycle regulation. The loss of p21 activation during this process is a critical factor leading to abnormal regulation of cell -cycle check points. Alterations in the levels of expression of cell -cycle regulators in this transgenic model are similar to those observed in human breast cancer. 24 In this study, we have determined that the in vitro and in vivo growth of mammary tumors derived from this transgenic model can be reduced by restoration of p21 function using a tetracycline (tet ) -inducible retroviral system and that p21 can serve as a target for gene therapy. We demonstrate that overexpression of p21 leads to reduced tumor growth associated with decreased cyclin /Cdk expression and increased apoptosis. The targeted overexpression of p21 may serve as a method for anticancer gene therapy.
MATERIALS AND METHODS

C3
( 1 ) / SV40 TAg transgenic mice and mammary carcinoma cells C3 ( 1) /TAg transgenic mice have been described previously 22 and maintained by breeding with wild -type FVB /N mice. Transgenic animals were identified by slot blot utilizing a 32 P -labeled SV40 -specific probe hybridized to mouse tail DNA. All manipulations of mice were performed in accordance with the guidelines of the Animal Care and Use Committee and in accordance with the procedures outlined in the Guide for the Care and Use of Laboratory Animals (National Institutes of Health Publication No. 1985 ) , under an animal study proposal ( LC -059) approved by the National Institute of Health Animal Care and Use Committee. Animals were euthanized by CO 2 asphyxiation.
Mammary carcinoma cell lines M6 was established from female C3 (1 ) /TAg transgenic mice (C.L. Jorcyk et al, in preparation) . The M6C line was derived from a lung metastasis following the subcutaneous ( s.c. ) injection of M6 cells into a nude mouse.
Histopathology
A portion of each mammary tissue sample was immediately frozen on dry ice for subsequent molecular biological analyses, whereas the remaining mammary tissue was fixed in 4% paraformaldehyde or 10% phosphate -buffered formalin, embedded in paraffin, cut at a thickness of 4 m, and stained with hematoxylin and eosin for histopathological examination.
Immunohistochemistry
Tissue sections were immersed in distilled water and heated by microwave for antigen retrieval 25 and the avidin ±biotin complex method was applied ( Vectastain ABC Elite Kit, Vector Laboratories, Burlingame, CA ) . Anti -p21 rabbit polyclonal Ab (C -19, dilution 1:100 ) from Santa Cruz Biotechnology, Santa Cruz, CA; anti -BrdU mouse monoclonal Ab ( Bu20a, 1:1000 ) from Dako, Carpinteria, CA were used. Immunofluorescence staining for p21 (C -19, Santa Cruz Biotechnology) was visualized using a streptavidin-conjugated Texas -red (NEN Life Science, Boston, MA ) under a fluorescence microscope.
Cell proliferation
Cells were plated into six -well plates and incubated in Dulbecco's modified Eagle's medium containing 5% fetal bovine serum with or without 2 g/mL tetracycline hydrochloride in an incubator with 5% CO 2 . The number of cells per well was counted using a hemocytometer. To evaluate DNA synthesis, cells were incubated for 30 minutes in culture medium containing 50 M 5 -bromo-2 H -deoxyuridine (BrdU; Sigma, St. Louis, MO ) and fixed thereafter in 3.7% formaldehyde in phosphate -buffered saline. DNA was denatured by a 20 -minute incubation in 4 N HCl for 20 minutes at 378C. The incorporated BrdU was then revealed by an anti -BrdU mouse monoclonal antibody (Bu20a, Dako ) . The number of S-phase cells incorporating BrdU into DNA per 1000 viable cells was counted in five to eight random high power fields (Â400) . BrdU labeling indices were expressed as a percentage of total cells counted.
Apoptosis
For quantitative analysis of apoptosis, growing cells on chamber-slides or 4 -m sections from paraffin-embedded tissues were assayed by the terminal deoxynucleotidyl transferase -mediated dUTP -digoxigenin nick end-labeling ( TUNEL ) method (Apop Tag; Oncor, Gaithersburg, MD ) . Growing cultured cells were fixed and the number of apoptotic cells were counted in a manner similar to that for the evaluation of BrdU labeling indices in vitro. The number of apoptotic cells in paraffin sections was counted in a population of up to 3000 mammary ductal cells contained within the same type of histologic lesion using an ocular micrometer disk (Fisher Scientific, Pittsburgh, PA ) . Levels of apoptosis were expressed as a percentage of the total cells counted. Sections from testes and thymus were used as positive controls. Because this technique may also stain cells undergoing necrotic death, areas of necrosis and regions immediately adjacent to necrotic areas within mammary carcinomas were excluded from the quantitation. To identify exfoliated apoptotic or dead cells within a culture plate, cells were stained with 27 M acridine orange and 25 M ethidium bromide and then visualized under a fluorescence microscope.
Western blotting
Tissues were homogenized and lysed with Triton X -100 ( 1.0% Triton X -100 /50 mM Tris ±HCl, pH 8.0 /150 mM NaCl ) buffer containing 100 mg /mL PMSF, 1 mg /mL aprotinin, and 180 mg /mL sodium orthovanadate. Culture cells were incubated with the lysis buffer on ice for 30 minutes. Extracts were then cleared by centrifugation, and protein concentrations were determined by the Bradford assay (Bio -Rad, Hercules, CA ) . Whole -cell lysates ( 10 or 20 g ) were fractionated by Tris ± glycine gels under reducing conditions and transferred onto nitrocellulose or PVDF membranes ( Immobilon -P; Millipore, Bedford, MA ) . After blocking with 3% bovine serum albumin, blots were incubated for 1 hour at room temperature with primary antibodies as follows:
, Cyclin E (M20 ) , Cdk 2 ( M2 ) , Cdk 4 ( C -22 ), and Cdk 6 ( C -21 ) from Santa Cruz Biotechnology; SV40 TAg (Ab -2 ) and p53 ( Ab -3 ) from Oncogene Science, Uniondale, NY; actin (N350 ) from Amersham Life Science, Arlington Heights, IL. The blots were then washed, incubated for 1 hour at room temperature with appropriate horseradish peroxidase -conjugated secondary Ab. Proteins were visualized using enhanced chemiluminescence ( NEN Life Science ).
Construction of a retroviral vector carrying inducible p21
A 417 -bp fragment of the p21 cDNA encoding the fulllength p21 protein was amplified by PCR using a plasmid containing the murine p21 cDNA (pGEM4Z -p21 -9C, kindly provided by Dr. J.F. Mushinski, National Cancer Institute, Bethesda, MD ) .
26 Primers used were: 5 H untranslated region, 5
H -CCA TAG TGA CCC GGA TCC TTC TT-3 H and 5 H -CCC ACC CGG GGA ATC TTC A -3 H . The underline indicates the introduction of a point mutation to generate a BamHI site. The generation of this PCR fragment removed two ATG sites present in the in 5 H untranslated region of the p21 cDNA. The original p21 plasmid was cut with SmaI and BamHI and replaced with the SmaI and BamHI PCR -generated p21 DNA fragment ( p21m Á 5 H ). The 0.7 -kb BamHI / EcoRI fragment was excised from the modified p21cDNA plasmid (p21m Á 5 H ), blunted with Klenow fragment, and cloned into PacI site of the pRetro -Off vector (ClonTech, Palo Alto, CA ) to generate (pRetro -Off-p21m Á 5 H ) . This vector contains both the tet -controlled transactivator (tTA ) coding sequence driven by the SV40 promoter and the tetresponsive element with minimum CMV promoter downstream of which the modified p21 cDNA was inserted. Orientation and correct sequence of the p21 insert was confirmed by sequencing. In this tet -regulable system, 27 Cancer Gene Therapy, Vol 8, No 1, 2001
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p21 integration using the tet -regulatable retroviral vector
The pRetro -Off vector containing the p21 gene ( pRetroOff-p21m Á 5 H ) was transfected into the BOSC23 packaging cell line 28 in the presence of tet to produce infectious retrovirus. M6 and M6C cells were infected with supernatant containing retrovirus 48 hours after the transfection from pRetro -Off-p21mÁ5
H or the pRetro -off vector and cloned under puromycin selection ( 4 g /mL ) in the presence of tet ( 2 g/ mL ) for 10 days. Single -cell clones were isolated using cloning cylinders (PGC Scientific, Frederick, MD ). Eighty clones from M6 and M6C cells infected with retrovirus carrying p21 ( pRetro -Off -p21m Á 5 H ) were examined for their ability to induce p21 and subsequent inhibition of cell growth with or without the addition of tet. Four clones demonstrated appreciable induction of p21. Other clones exhibited high basal levels of p21 expression. Twenty clones containing only the pRetro -off vector were isolated as control cell lines.
Southern blot
A 2.0-kb EcoRI /XhoI fragment of the pReto -Off vector was labeled with [ -32 P] dCTP by random oligonucleotide primed synthesis and used as a hybridization probe. Twenty micrograms of genomic DNA extracted from cells was digested with EcoRI and XhoI and fractionated on a 1.0% agarose gel, transferred to a nylon membrane, and fixed by UV cross -linking. The membrane was hybridized with the 32 P -labeled probe and rinsed using standard protocols and autoradiography was performed.
Tumorigenicity study
Female Nrl:Nu /Nu nude mice ( 8-to 10 -week old ) were obtained from Charles River, Frederick, MD, for tumorgenicity studies. Mammary carcinoma cells (1Â10 5 cells / 0.2 mL in PBS ) carrying the p21 gene (pRetro -Offp21m Á 5 H ) or the pRetro -off vector were inoculated s.c. into the right flank of the nude mice. A total of 10 mice were injected with each clone. Three clones carrying vector alone ( M6C -Rvec#2 and #10, and M6 -Rvec#4) and five clones carrying p21 gene (M6C -Rp21#4 -11, #4-12 and #8 -1 and M6 -Rp21#10 -1) were tested. Five mice from each group received 200 g /mL tetracycline hydrochloride ( Sigma) in 2.5% sucrose in their drinking water using light -opaque bottles. The remaining five mice in each group were administered 2.5% sucrose alone in drinking water. Drinking water containing tet was changed every 3 days. Subcutaneous tumor size was measured weekly using a caliper and tumor volume was calculated using the following formula: the largest diameterÂ (the smallest diameter ) 2 Â0.4. 29 Individual body weight was recorded weekly. Subcutaneous masses were removed, immediately fixed in 10% phosphate -buffered formalin, and tissue sections were assayed for p21 immunoreactivity and apoptosis using the TUNEL assay. A portion of each sample was also immediately frozen in liquid nitrogen for molecular analyses.
Statistical analysis
The two -sided Student's t test was used to determine whether significant differences existed between the mean values of the groups analyzed.
RESULTS
Retroviral integration of p21 -inducible vectors into mammary cancer cell lines
To test the hypothesis that p21 was directly responsible for the observed changes in regulators of the cell -cycle machinery, we established a retroviral system to deliver p21 to M6 and M6C tumor cells under the inducible control of tet. The retroviral vector offers a high rate of gene delivery to the target cells. We found no toxicity associated with the administration of tet. All effects on tumor growth in our experiments, therefore, appear to be the result of the induction of p21. Mammary carcinoma cells were infected with the retroviral vector carrying the mouse p21 cDNA ( Rp21 ) and 20 clonal cell lines were derived from each parent line designated M6 -Rp21 and M6C -Rp21. Genomic integration of the retroviral vectors into the mammary carcinoma cells was confirmed by Southern blot analyses. Twenty micrograms of genomic DNA was digested with XhoI and EcoRI. Cells carrying vector alone ( M6 -Rvec and M6C -Rvec ) demonstrated the expected 2.0-kb fragment, whereas cells carrying the inserted p21 gene (M6 -Rp21, M6C -Rp21 ) showed the SHIBATA, YOSHIDOME, SHIBATA, ET AL: SUPPRESSION OF MAMMARY CANCER GROWTH BY p21 expected 2.7-kb fragment ( Fig 2A ) . No rearrangements of the retroviral genome were observed.
Alterations in the expression of cell -cycle regulators following p21 induction
M6 -Rp21 and M6C -Rp21 cells grown with tet supplementation expressed low levels of p21 as expected ( Fig 2B ) , whereas expression of p21 was induced in M6 -Rp21 and M6C -Rp21 withdrawal of tet for 24 hours ( Fig 2C and D ) . Approximately 10 ±20% of M6 -Rp21 and M6C -Rp21 cells demonstrated expression of p21 8 hours after the withdrawal of tetracycline, 30± 40% after 24 hours, 50 ±80% after 48 hours, and greater than 90% after 72 hours in the absence of tet as assessed by immunohistochemistry. Occasionally, cells overexpressing p21 showed fragmented and shrunken nuclei ( Fig 2D and E ) , suggesting apoptotic cell death. Changes in the expression levels of several cell -cycle regulators following the induction of p21 are shown in Figure 3A .
High levels of p21 protein were induced in M6 -Rp21 and M6C -Rp21 cells 72 hours after the withdrawal of tet. Levels of cyclin D1, Cdk 2, Cdk 4, and Cdk 6 decreased when p21 was induced. However, no significant changes in the levels of cyclin E, Cdk2, Rb phosphorylation, or E2F1 expression were observed when p21 was induced (Fig 3B and C ) . Interestingly, p27
Kpi1 (p27 ) levels decreased when p21 was overexpressed ( Fig 3A ) .
Inhibition of cell growth and DNA synthesis following induction of p21 expression
The growth properties of each cell line were compared with or without the induced expression of p21. Although the growth rate of the M6 -Rvec and M6C -Rvec was similar with or without the addition of tet (Fig 4A ) , in vitro cell growth was significantly inhibited when p21 was induced through the withdrawal of tet ( Fig 4B ) . DNA synthesis, as assessed by BrdU incorporation, was significantly reduced in M6 -Rp21 and M6C -Rp21 with p21 induction, compared to cells in which p21 was not induced (Fig 4D ) . No differences in BrdU labeling indices were observed in the M6 -Rvec and M6C -Rvec cells whose retroviral vector did not contain p21, regardless of whether or not tet was added to the media ( Fig  4C ) . Following the induction of p21 expression for 3 days in M6 -Rp21 and M6C -Rp21 cells, cell morphology changed and cells grew in aggregates ( Fig 5B ) . Aggregate formation was not observed in cells without p21 induction (Fig 5A ) or in cells containing vector alone (Fig 5C and D ) . The size of the aggregates became larger after 9 days of p21 induction. Staining with acridine orange and ethidium bromide demonstrated that the aggregates with p21 induction contained many more dead cells (Fig 5F ) compared to cells carrying the vector alone ( M6 -Rvec and M6C -Rvec ) ( Fig  5E ) . However, relatively low numbers of dead cells were found in the areas where aggregates did not form ( Fig 5F,  inset ) compared to areas of aggregate formation. Because the aggregates did not adhere well to the culture dishes, the TUNEL staining could not be performed in vitro to determine whether cells were undergoing apoptosis.
Effect of p21 expression on tumorgenicity in nude mice
We wished to determine whether the inducible expression of p21 could retard tumor growth when the retrovirally engineered cells were injected into nude mice. No toxicity In mammary carcinoma cells carrying vector alone ( M6C -Rvec ) , rates of the cell growth were similar with or without the addition of tetracycline ( tet ) . B: In mammary carcinoma cells carrying p21 ( M6C -Rp21 ) , however, the cell growth was significantly retarded with overexpression of p21 following withdrawal of tet compared to cells without p21 induction in the presence of tet ( *P < .05; **P < .01 ) . C,D: BrdU labeling indices were similar in the carcinoma cells carrying vector alone ( M6C -Rvec ) regardless of tet treatment ( C ) , whereas a significant decrease in labeling indices was observed in the carcinoma cells ( M6C -Rp21 ) with overexpression of p21 after 5 and 9 days of tet withdrawal ( *P < .05; **P < .01 ) ( D ) .
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SHIBATA, YOSHIDOME, SHIBATA, ET AL: SUPPRESSION OF MAMMARY CANCER GROWTH BY p21 was observed when mice were given tet. Water intake was similar in mice given tet -supplemented or nonsupplemented water. Average tet intake was 202 to 228 mg / kg body weight per day in each group, 6 weeks after inoculation of the cells into the mice. Body weights were not statistically different between tet -treated and nontreated groups during the course of the experiments. Tumor growth and volume were similar in mice that received cells with vector alone ( M6 -Rvec and M6C -Rvec ) regardless of whether or not they received tet supplementation in their drinking water ( Fig 6A ) . However, tumor volumes were much smaller in mice in which p21 was induced compared to mice that received the same cells but without the induction of p21 expression. Figure 6 . A ± E: Effect of induced -p21 expression on tumor volume ( A ) , apoptosis ( B ) and expression of cell -cycle regulators ( C ± E ) in mammary carcinomas which developed in nude mice. A: Tumor volumes of the mammary carcinomas carrying vector alone ( clone M6C -Rvec10L ) were similar regardless of tet treatment. Tumor volumes from implanted clone M6C -Rp21#4 -21 cells were significantly decreased in nude mice with p21 induction following tet withdrawal compared to tumor volumes observed in nude mice without p21 induction at 9 weeks after cell inoculation ( *P < .05 ) . M6 -Rp21#10 -1 showed a significant reduction in tumor volumes under condition of p21 on during weeks 11 ± 14 ( *P < .05 ) . However, M6C -Rp21#4 -22 showed tendency for a decrease of tumor volumes but not significant. B: There appeared to be a higher background level of apoptosis in M6C -Rp21 tumors ( clone#4 -21 ) regardless of tet treatment compared to that in M6C -Rvec tumors ( clone#10 -L ) . Levels of apoptosis were significantly higher in M6C -Rp21 tumors with p21 induction ( no tet ) compared to apoptosis levels in M6C -Rvec tumors without tet ( *P < .05 ) . However, levels of apoptosis were not significantly different between tumors arising from M6C -Rp21 cells with tet and without tet ( B ) . N.S., not significant. C: Induction of p21 in M6 -Rp21 and M6C -Rp21 in the absence of tet correlates to decreased levels of p27, cyclin D1, Cdk 2, Cdk 4, and Cdk 6 in tumors in vivo. No changes were observed in expression of p21, cyclins or Cdks in M6 -Rvec cells with or without tet. Western blot analysis ( clones: M6C -Rp21#4 -21 and M6C -Rvec#10L ) . D,E: Induction of p21 expression in mammary carcinoma cells implanted into nude mice. Extremely low levels of p21 expression was seen in M6C -Rp21 mammary carcinomas from nude mice receiving tet ( D ) , whereas high levels of p21 expression were induced in M6C -Rp21 mammary carcinomas from nude mice in the absence of tet ( clone: M6C -Rp21#4 -21 ) ( E ) . p21 immunohistochemistry. Â200.
Cancer Gene Therapy, Vol 8, No 1, 2001 In mice receiving M6C -Rp21#4 -21 cells, tumor volumes measured 9 weeks after cell inoculation were significantly reduced by the induction of p21 (Fig 6A ) . In mice receiving M6 -Rp21#10 -1 cells, tumor volumes after 11± 14 weeks were significantly smaller in mice when p21 was induced ( without tet ) than that observed in mice where p21 was not induced ( with tet ) (Fig 6A ) . Tumor volumes in mice that were injected with either clone M6C -Rp21#4-22 or M6C -Rp21#8 -1 tended to be lower with the induction of p21, but this was not statistically significant. All tumors that developed from all clones were histologically indistinguishable as moderate -differentiated adenocarcinomas with central necrosis.
Levels of apoptosis, as evaluated by the TUNEL assay, tended to be higher in the mammary carcinoma cells carrying the inducible p21 vector ( whether or not p21 was induced by tet ) compared to apoptosis levels observed in cells containing the vector alone ( Fig 6B ) . This suggests that this inducible vector may allow for a small amount of p21 to be produced under conditions where expression has not been induced. The induction of p21, however, resulted in elevated levels of apoptosis compared to the same cells where p21 was not induced.
The induction of p21 in M6 -Rp21 and M6C -Rp21 cells grown in nude mice was confirmed by Western blotting ( Fig  6C ) and immunohistochemistry ( Fig 6D and E ) . Induction of p21 resulted in reduced cyclins and Cdk levels, similar to those observed in the in vitro studies (Fig 6C ) . There was no reduction in Rb phosphorylation or E2F1 expression, however, by p21 induction despite the reduced levels of cyclins and Cdks (data not shown ) .
DISCUSSION
In the C3 (1 ) /TAg transgenic mouse model of mammary cancer, the p21 pathway of cell -cycle regulation is dysfunctional during mammary tumor progression. We have demonstrated that restoration of this signaling pathway can inhibit tumor growth both in vitro and in vivo.
The inhibition of the p21 pathway appears to occur indirectly through the action of Tag (Fig 1) . It is well established that TAg binds to and functionally inactivates the tumor suppressors p53 and Rb. 30 Because p53 is a key regulator of p21 induction, extremely low levels of p21 in the mammary tumors likely results from the loss of p53 function by TAg. 20, 31 Because the p21 Cdk inhibitor cannot be activated by p53 under these circumstances, levels of cyclin D1, cyclin E, Cdk 2, Cdk 4, and Cdk 6 become elevated during mammary tumor progression. 32 The elevation of cyclins and Cdks presumably leads to increased levels of Rb phosphorylation and E2F1 as observed in the mammary tumors. Thus, it appears that the TAg -induced inhibition of the p21 response leads to abnormal cell -cycle progression involved in tumor development in this model. 33 The alterations in cyclin/ Cdk levels in this transgenic mouse model are similar to those reported in human breast cancer. 24 The direct inducible overexpression of p21 in the mammary carcinoma cells using a retroviral system resulted in a significant inhibition of cell growth and DNA synthesis in vitro compared to cells in which p21 was not induced. Overexpression of p21 using the retroviral system resulted in decreased levels of cyclin D1, Cdk 4, and Cdk 6. These results suggested that the inducible p21 retroviral vector might be a potential anticancer strategy for this model of mammary cancer.
We observed variability in growth responses to p21 induction between different clones tested. Two clones demonstrated that the induction of p21 resulted in a significant inhibition of tumor growth associated with increased levels of apoptotic cell death. Two other clones showed only a tendency for decreased tumor volumes with a large variation in tumor volumes. The levels of p21 induction also varied among different clones ( Fig  6C ) and between tumor cells from the same clone ( Fig  6E ) . This demonstrates that although the induction of p21 can be effective in retarding tumor growth, the tetresponsive retroviral delivery system used in these studies appears to give variable results. In addition, our in vitro studies demonstrated that the induction of p21 reduced the rate of DNA synthesis by about 50%. It is possible that a delivery system that can produce higher levels of p21 might increase this effect further. Alternatively, p21 gene therapy used in combination with other therapies might have a more profound effect in inhibiting tumor growth.
When p21 was induced in the same cells in vivo, there was no observable reduction in Rb phosphorylation or E2F1 expression, despite a reduction in the levels of cyclins/Cdk. Nonetheless, tumor growth was significantly reduced for two clones by p21. It is possible that the level of p21 induction in vivo was not sufficient to reduce Rb phosphorylation or that Rb phosphorylation and E2F1 expression may also be regulated by another pathway.
The role of p21 in inducing apoptosis, however, remains controversial. p21 has been reported to induce apoptosis in human breast and colorectal carcinoma, 14, 16 whereas it does not alter apoptosis in rat pheochromocytoma cells and murine melanoma cells. 15, 17 This suggests that the induction of apoptosis by p21 might be tissue specific. In our in vitro studies, localized regions of apoptotic cells were observed in the cell aggregates that formed in vitro. However, although the levels of apoptosis were increased in cells overexpressing p21 compared to cells carrying the vector alone, the levels were not extremely high. Because p21 can arrest cells at the G1 ± S and G2 ± M phases, it is possible that the cell -cycle arrest may induce apoptosis through another mechanism. It is, therefore, possible that p21 may not directly induce apoptosis. SHIBATA, YOSHIDOME, SHIBATA, ET AL: SUPPRESSION OF MAMMARY CANCER GROWTH BY p21
The Cdk inhibitor p27 shares many functions which overlap those of p21. Both modulate the enzymatic activity of cyclin /Cdk complexes 34 through inactivation of cyclin D1 / Cdk 4 /6 and cyclin E /Cdk 2 complexes. Our in vitro and in vivo results demonstrate that there was a reciprocal response in the expression of p21 and p27. Decreased levels of p27 were found in cells overexpressing p21 and lack of p27 expression was associated with higher levels of p21. A similar reciprocal response in p21 and p27 expression has been reported in lymphoid cell lines 35 and in human epidermoid carcinoma cells (A431 ) treated with epidermal growth factor. 36 In that study, the reduced expression of p27 led to mitogenic stimulation, although, this did not occur in the present experiments because of the concomitant overexpression of p21. However, it remains unclear why this reciprocal expression of p21 and p27 occurs and suggests that these tumor cells prevent their co -expression. p21 deficiency has been associated with increased tumorigenesis in other model systems. Loss of p21 in keratinocytes infected with an activated ras accelerates tumor formation. 37 Mammary tumor progression in Wnt -1 transgenic mice is accelerated in combination with p21 mutant alleles. 19 Although p21 mutations in human breast carcinomas are relatively infrequent, 38 ,39 the absence of p21 expression is associated with a high risk of breast cancer recurrence. 9 Thus, p21 deficiency can influence tumor formation and progression.
In the present study, we have demonstrated, using a retroviral system, that the restoration of p21 function in mammary tumor cells that lack expression of p21 can significantly reduce tumor growth in vitro as well as in vivo due to inhibition of cell -cycle progression and possibly increased apoptosis. The potential use of p21 for suppressing tumor growth, perhaps as an adjuvant to other therapies, will be significantly enhanced by the development of improved gene therapy targeting vectors which provide consistently high levels of expression.
